Investor Insights - I Healthier

Aurobindo Pharma USFDA Approval: Is It the Best Move Yet?

October 5, 2026 Ethan Cook

Aurobindo Pharma USFDA approval has sparked a rally, reaching a new 52-week high. Discover what this means for investors.

You missed

Aurobindo Pharma USFDA Approval: Is It the Best Move Yet?

October 5, 2026 Ethan Cook

Sava Healthcare acquisition: Proven benefits for Zenex Animal Health

September 30, 2026 Ethan Cook

FDA Approval Apixaban Suspension: A Proven Breakthrough

September 28, 2026 Ethan Cook

Novo Turnaround Plan: Is It the Best Strategy for Success?

September 23, 2026 Ethan Cook